The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Skin Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Skin Diseases


Psychiatry related information on Skin Diseases

  • Significant correlations were noted between psychopathology (GHQ CRPS), dysfunction as per Dysfunction Analysis Questionnaire (DAQ), and behavior change as per Impact of Skin Disease Scale (IMPACT), and all were more prominent in vitiligo [6].

High impact information on Skin Diseases


Chemical compound and disease context of Skin Diseases


Biological context of Skin Diseases


Anatomical context of Skin Diseases


Gene context of Skin Diseases


Analytical, diagnostic and therapeutic context of Skin Diseases


  1. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). Rock, B., Martins, C.R., Theofilopoulos, A.N., Balderas, R.S., Anhalt, G.J., Labib, R.S., Futamura, S., Rivitti, E.A., Diaz, L.A. N. Engl. J. Med. (1989) [Pubmed]
  2. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cheng, J., Syder, A.J., Yu, Q.C., Letai, A., Paller, A.S., Fuchs, E. Cell (1992) [Pubmed]
  3. Porphyria cutanea tarda in three generations of a single family. Benedetto, A.V., Kushner, J.P., Taylor, J.S. N. Engl. J. Med. (1978) [Pubmed]
  4. Induction and function of vascular adhesion protein-1 at sites of inflammation. Salmi, M., Kalimo, K., Jalkanen, S. J. Exp. Med. (1993) [Pubmed]
  5. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). Gutierrez-Steil, C., Wrone-Smith, T., Sun, X., Krueger, J.G., Coven, T., Nickoloff, B.J. J. Clin. Invest. (1998) [Pubmed]
  6. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. Mattoo, S.K., Handa, S., Kaur, I., Gupta, N., Malhotra, R. J. Dermatol. (2001) [Pubmed]
  7. Genetic and clinical mosaicism in a type of epidermal nevus. Paller, A.S., Syder, A.J., Chan, Y.M., Yu, Q.C., Hutton, E., Tadini, G., Fuchs, E. N. Engl. J. Med. (1994) [Pubmed]
  8. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Amagai, M., Klaus-Kovtun, V., Stanley, J.R. Cell (1991) [Pubmed]
  9. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Wilson, J.B., Weinberg, W., Johnson, R., Yuspa, S., Levine, A.J. Cell (1990) [Pubmed]
  10. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., Krieg, T., Rajewsky, K., Haase, I. Nature (2002) [Pubmed]
  11. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. De Bosscher, K., Vanden Berghe, W., Haegeman, G. Endocr. Rev. (2003) [Pubmed]
  12. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. Domloge-Hultsch, N., Gammon, W.R., Briggaman, R.A., Gil, S.G., Carter, W.G., Yancey, K.B. J. Clin. Invest. (1992) [Pubmed]
  13. Cyclosporin and skin disease. Aldridge, R.D., Simpson, J.G., Whiting, P.H., Thomson, A.W. Lancet (1985) [Pubmed]
  14. Treatment of lamellar ichthyosis and other keratinising dermatoses with an oral synthetic retinoid. Peck, G.L., Yoder, F.W. Lancet (1976) [Pubmed]
  15. Leukotriene-B4-like immunoreactivity and skin disease. Greaves, M., Barr, R., Camp, R. Lancet (1984) [Pubmed]
  16. Dermatitis herpetiformis: the skin and the gut. Katz, S.I., Hall, R.P., Lawley, T.J., Strober, W. Ann. Intern. Med. (1980) [Pubmed]
  17. The role of complement in experimental bullous pemphigoid. Liu, Z., Giudice, G.J., Swartz, S.J., Fairley, J.A., Till, G.O., Troy, J.L., Diaz, L.A. J. Clin. Invest. (1995) [Pubmed]
  18. Genetic skin diseases caused by mutations in keratin intermediate filaments. Steinert, P.M., Bale, S.J. Trends Genet. (1993) [Pubmed]
  19. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. Laskin, J.D., Lee, E., Yurkow, E.J., Laskin, D.L., Gallo, M.A. Proc. Natl. Acad. Sci. U.S.A. (1985) [Pubmed]
  20. Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations. Di, W.L., Monypenny, J., Common, J.E., Kennedy, C.T., Holland, K.A., Leigh, I.M., Rugg, E.L., Zicha, D., Kelsell, D.P. Hum. Mol. Genet. (2002) [Pubmed]
  21. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Frazer, I.H., Leippe, D.M., Dunn, L.A., Liem, A., Tindle, R.W., Fernando, G.J., Phelps, W.C., Lambert, P.F. Cancer Res. (1995) [Pubmed]
  22. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Hida, S., Ogasawara, K., Sato, K., Abe, M., Takayanagi, H., Yokochi, T., Sato, T., Hirose, S., Shirai, T., Taki, S., Taniguchi, T. Immunity (2000) [Pubmed]
  23. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. Wassom, D.L., Loegering, D.A., Solley, G.O., Moore, S.B., Schooley, R.T., Fauci, A.S., Gleich, G.J. J. Clin. Invest. (1981) [Pubmed]
  24. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells. Javier, A.F., Bata-Csorgo, Z., Ellis, C.N., Kang, S., Voorhees, J.J., Cooper, K.D. J. Clin. Invest. (1997) [Pubmed]
  25. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Oyama, N., Chan, I., Neill, S.M., South, A.P., Wojnarowska, F., Kawakami, Y., D'Cruz, D., Mepani, K., Hughes, G.J., Bhogal, B.S., Kaneko, F., Black, M.M., McGrath, J.A. J. Clin. Invest. (2004) [Pubmed]
  26. A cell surface desmosome-associated component: identification of tissue-specific cell adhesion molecule. Jones, J.C., Yokoo, K.M., Goldman, R.D. Proc. Natl. Acad. Sci. U.S.A. (1986) [Pubmed]
  27. Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. Syder, A.J., Yu, Q.C., Paller, A.S., Giudice, G., Pearson, R., Fuchs, E. J. Clin. Invest. (1994) [Pubmed]
  28. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. Liu, Z., Li, N., Diaz, L.A., Shipley, M., Senior, R.M., Werb, Z. J. Clin. Invest. (2005) [Pubmed]
  29. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. Nickoloff, B.J., Nestle, F.O., Zheng, X.G., Turka, L.A. Blood (1994) [Pubmed]
  30. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Christopherson, K.W., Hood, A.F., Travers, J.B., Ramsey, H., Hromas, R.A. Blood (2003) [Pubmed]
  31. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. Ishii, K., Amagai, M., Hall, R.P., Hashimoto, T., Takayanagi, A., Gamou, S., Shimizu, N., Nishikawa, T. J. Immunol. (1997) [Pubmed]
  32. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Glaspy, J.A., Baldwin, G.C., Robertson, P.A., Souza, L., Vincent, M., Ambersley, J., Golde, D.W. Ann. Intern. Med. (1988) [Pubmed]
  33. Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis. Flotte, T.J., Baird, L.G. J. Immunol. (1986) [Pubmed]
  34. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA. Rico, M.J., Korman, N.J., Stanley, J.R., Tanaka, T., Hall, R.P. J. Immunol. (1990) [Pubmed]
  35. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. Wang, L.F., Lin, J.Y., Hsieh, K.H., Lin, R.H. J. Immunol. (1996) [Pubmed]
  36. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. Labib, R.S., Anhalt, G.J., Patel, H.P., Mutasim, D.F., Diaz, L.A. J. Immunol. (1986) [Pubmed]
WikiGenes - Universities